Pharmacotherapy of multiple sclerosis: the PROOF trial.

about

Pharmacotherapy of multiple sclerosis: the PROOF trial.

Item

http://www.wikidata.org/entity/Q47743703

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@en

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@nl

type

Item

label

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@en

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@nl

prefLabel

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@en

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@nl

P1476

Pharmacotherapy of multiple sclerosis: the PROOF trial.

@en

P2093

Aaron Boster

http://www.w3.org/2001/XMLSchema#string

Michael K Racke

http://www.w3.org/2001/XMLSchema#string

P2860

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN).

A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients.

Twenty-four-month comparison of immunomodulatory treatments - a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone).

Rationale and design of the prospective and retrospective observational study of Avonex and Rebif (PROOF) for the treatment of relapsing-remitting multiple sclerosis.

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

Effects of interferon beta-1a and -1b over time: 6-year results of an observational head-to-head study.

A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.

Interferon beta in relapsing–remitting multiple sclerosis

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

P304

1235-1237

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1517/14656560902927856

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19463066

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy